Horizontal transfer of blaCMY-bearing plasmids among clinical Escherichia coli and Klebsiella pneumoniae isolates and emergence of cefepime-hydrolyzing CMY-19

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 2, 2006, Pages 534-541

  Wachino, Jun Ichi ^a,b   Kurokawa, Hiroshi ^a   Suzuki, Satowa ^a   Yamane, Kunikazu ^a   Shibata, Naohiro ^a   Kimura, Kouji ^a   Ike, Yasuyoshi ^b   Arakawa, Yoshichika ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOBENZENEBORONIC ACID; AMINOPHENOL DERIVATIVE; AMPICILLIN; AZTREONAM; BETA LACTAMASE; CEFALORIDINE; CEFALOTIN; CEFEPIME; CEFMETAZOLE; CEFMINOX; CEFOTAXIME; CEFOXITIN; CEFPIROME; CEFTAZIDIME; CEFTIZOXIME; CEPHALOSPORIN DERIVATIVE; CEPHAMYCIN; IMIPENEM; LATAMOXEF; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PROTEIN CMY 19; PROTEIN CMY 9; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; BLA CMY9 GENE; CMY 19 GENE; ENZYME KINETICS; ENZYME LOCALIZATION; ENZYME PURIFICATION; ESCHERICHIA COLI; GENE TRANSFER; HYDROLYSIS; KLEBSIELLA PNEUMONIAE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POINT MUTATION; PRIORITY JOURNAL; AMINO ACID SEQUENCE; DRUG EFFECT; GENETICS; HORIZONTAL GENE TRANSFER; HUMAN; ISOELECTRIC FOCUSING; METABOLISM; MOLECULAR GENETICS; PULSED FIELD GEL ELECTROPHORESIS; SOUTHERN BLOTTING; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BLOTTING, SOUTHERN; CEPHALOSPORINS; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; GENE TRANSFER, HORIZONTAL; HUMANS; ISOELECTRIC FOCUSING; KLEBSIELLA PNEUMONIAE; MOLECULAR SEQUENCE DATA; PLASMIDS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 31944451748     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.2.534-541.2006     Document Type: Article

References (33)

1. Ambler, R. P. 1980. The structure of β-lactamases. Philos. Trans. R. Soc. London B Biol. Sci. 289:321-331.
2. Arakawa, Y., N. Shibata, K. Shibayama, H. Kurokawa, T. Vagi, H. Fujiwara, and M. Goto. 2000. Convenient test for screening metallo-β-lactamase- producing gram-negative bacteria by using thiol compounds. J. Clin. Microbiol. 38:40-43.
3. Armand-Lefevre, L., V. Leflon-Guibout, J. Bredin, F. Barguellil, A. Amor, J. M. Pages, and M. H. Nicolas-Chanoine. 2003. Imipenem resistance in Salmonella enterica serovar Wien related to porin loss and CMY-4 β-lactamase production. Antimicrob. Agents Chemother. 47:1165-1168.
4. Barlow, M., and B. G. Hall. 2003. Experimental prediction of the evolution of cefepime resistance from the CMY-2 AmpC β-lactamase. Genetics 164:23-29.
5. Barnaud, G., Y. Benzerara, J. Gravisse, L. Raskine, M. J. Sanson-Le Pors, R. Labia, and G. Ariel. 2004. Selection during cefepime treatment of a new cephalosporinase variant with extended-spectrum resistance to cefepime in an Enterobacter aerogenes clinical isolate. Antimicrob. Agents Chemother. 48:1040-1042.
6. Barnaud, G., R. Labia, L. Raskine, M. J. Sanson-Le Pors, A. Philippen, and G. Ariel. 2001. Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate. FEMS Microbiol. Lett. 195:185-190.
7. CMY-1 gene and its relationship with other β-lactamase genes. Antimicrob. Agents Chemother. 40:1926-1930.
8. Bauernfeind, A., Y. Chong, and S. Schweighart 1989. Extended broad-spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection 17:316-321.
9. Bradford, P. A., C. Urban, N. Mariano, S. J. Projan, J. J. Rahal, and K. Bush. 1997. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob. Agents Chemother. 41:563-569.
10. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
11. Chapman, T. M., and C. M. Perry. 2003. Cefepime: a review of its use in the management of hospitalized patients with pneumonia. Am. J. Respir. Med. 2:75-107.
12. Doi, Y., N. Shibata, K. Shibayama, K. Kamachi, H. Kurokawa, K. Yokoyama, T. Yagi, and Y. Arakawa. 2002. Characterization of a novel plasmid-mediated cephalosporinase (CMY-9) and its genetic environment in an Escherichia coli clinical isolate. Antimicrob. Agents Chemother. 46:2427-2434.
13. Doi, Y., J. Wachino, M. Ishiguro, H. Kurokawa, K. Yamane, N. Shibata, K. Shibayama, K. Yokoyama, H. Kato, T. Yagi, and Y. Arakawa. 2004. Inhibitor-sensitive AmpC β-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins. Antimicrob. Agents Chemother. 48:2652-2658.
14. Fosse, T., C. Giraud-Morin, I. Madinier, and R. Labia. 2003. Sequence analysis and biochemical characterisation of chromosomal CAV-1 (Aeromonas caviae), the parental cephalosporinase of plasmid-mediated AmpC 'FOX' cluster. FEMS Microbiol. Lett. 222:93-98.
15. Gonzalez Leiza, M., J. C. Perez-Diaz, J. Ayala, J. M. Casellas, J. Martinez-Beltran, K. Bush, and F. Baquero. 1994. Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated β-lactamase with two molecular variants. Antimicrob. Agents Chemother. 38:2150-2157.
16. Horii, T., Y. Arakawa, M. Ohta, S. Ichiyama, R. Wacharotayankun, and N. Kato. 1993. Plasmid-mediated AmpC-type β-lactamase isolated from Klebsiella pneumoniae confers resistance to broad-spectrum β-lactams, including moxalactam. Antimicrob. Agents Chemother. 37:984-990.
17. Kado, C. I., and S. T. Liu. 1981. Rapid procedure for detection and isolation of large and small plasmids. J. Bacteriol. 145:1365-1373.
18. Kim, J. Y., J. S. Song, S. H. Bak, Y. E. Cho, D. W. Kim, S. H. Jeong, Y. M. Park, K. J. Lee, and S. H. Lee. 2004. Dissemination of Escherichia coli producing AmpC-type β-lactamase (CMY-11) in Korea. Int. J. Antimicrob. Agents 24:320-326.
19. Lee, J. H., H. I. Jung, J. H. Jung, J. S. Park, J. B. Ahn, S. H. Jeong, B. C. Jeong, and S. H. Lee. 2004. Dissemination of transferable AmpC-type β-lactamase (CMY-10) in a Korean hospital. Microb. Drug Resist. 10:224-230.
20. CMY-10, a novel plasmid-encoded AmpC-type β-lactamase gene in a clinical isolate of Enterobacter aerogenes. J. Appl. Microbiol. 95:744-752.
21. CMY-11, an AmpC-type plasmid-mediated β-lactamase gene in a Korean clinical isolate of Escherichia coli. J. Antimicrob. Chemother. 49:269-273.
22. Mammeri, H., L. Poirel, P. Bemer, H. Drugeon, and P. Nordmann. 2004. Resistance to cefepime and cefpirome due to a 4-amino-acid deletion in the chromosome-encoded AmpC β-lactamase of a Serratia marcescens clinical isolate. Antimicrob. Agents Chemother. 48:716-720.
23. Nakano, R., R. Okamoto, Y. Nakano, K. Kaneko, N. Okitsu, Y. Hosaka, and M. Inoue. 2004. CFE-1, a novel plasmid-encoded AmpC β-lactamase with an ampR gene originating from Citrobacter freundii. Antimicrob. Agents Chemother. 48:1151-1158.
24. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. Document M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
25. Philippen, A., G. Ariel, and G. A. Jacoby. 2002. Plasmid-determined AmpC-type β-lactamases. Antimicrob. Agents Chemother. 46:1-11.
26. Queenan, A. M., S. Jenkins, and K. Bush. 2001. Cloning and biochemical characterization of FOX-5, an AmpC-type plasmid-encoded β-lactamase from a New York City Klebsiella pneumoniae clinical isolate. Antimicrob. Agents Chemother. 45:3189-3194.
27. Sanders, C. C. 1987. Chromosomal cephalosporinases responsible for multiple resistance to newer β-lactam antibiotics. Annu. Rev. Microbiol. 41:573-593.
28. Shibata, N., Y. Doi, K. Yamane, T. Yagi, H. Kurokawa, K. Shibayama, H. Kato, K. Kai, and Y. Arakawa. 2003. PCR typing of genetic determinants for metallo-β-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron. J. Clin. Microbiol. 41:5407-5413.
29. Stapleton, P. D., K. P. Shannon, and G. L. French. 1999. Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 β-lactamase production and loss of an outer membrane protein. Antimicrob. Agents Chemother. 43:1206-1210.
30. Wachino, J., Y. Doi, K. Yamane, N. Shibata, T. Yagi, T. Kubota, and Y. Arakawa. 2004. Molecular characterization of a cephamycin-hydrolyzing and inhibitor-resistant class A β-lactamase, GES-4, possessing a single G170S substitution in the omega-loop. Antimicrob. Agents Chemother. 48:2905-2910.
31. Wachino, J., Y. Doi, K. Yamane, N. Shibata, T. Yagi, T. Kubota, H. Ho, and Y. Arakawa. 2004. Nosocomial spread of ceftazidime-resistant Klebsiella pneumomae strains producing a novel class a β-lactamase, GES-3, in a neonatal intensive care unit in Japan. Antimicrob. Agents Chemother. 48:1960-1967.
32. Yagi, T., J. Wachino, H. Kurokawa, K. Yamane, Y. Doi, N. Shibata, H. Kato, K. Shibayama, and Y. Arakawa. 2004. Practical methods for identification of class C β-lactamase-producing Klebsiella pneumoniae and Escherichia coli using boronic acid compounds. J. Clin. Microbiol. 43:2551-2558.
33. Yan, J. J., S. M. Wu, S. H. Tsai, J. J. Wu, and I. J. Su. 2000. Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum β-lactamases and identification of a novel AmpC enzyme (CMY-8) in southern Taiwan. Antimicrob. Agents Chemother. 44:1438-1442.